scientific-precision-oncology

Annotate somatic cancer variants by integrating CIViC, OncoKB, cBioPortal, COSMIC, and GDC/TCGA to generate a coherent view of actionable oncology insights. This cross-database variant annotation surfaces evidence-based therapy decisions from standardized tumor genomic inputs.

Generate Molecular Tumor Board reports by inputting standardized tumor variants and running CIViC and OncoKB annotations. The process translates tumor genomic profiles into prioritized therapy recommendations and MTB-ready clinical documentation.

Variant actionability scoring assesses somatic cancer variants across tumor types using integrated knowledge bases to prioritize treatments. Evidence filtering applies actionability levels from sources like CIViC and OncoKB to surface relevant clinical trial options.

Cross-database variant annotation from cBioPortal, COSMIC, and GDC/TCGA requires external API access and standardized variant inputs. Robust error handling ensures reproducible research when querying these knowledge bases for actionable oncology insights.

Consolidate CIViC and OncoKB evidence levels by integrating them alongside cBioPortal, COSMIC, and GDC/TCGA data into a unified annotation. This applies actionability scoring across tumor types to guide evidence-based targeted therapy decisions.

Variant annotation fails without standardized inputs because querying external APIs like CIViC, OncoKB, and cBioPortal requires structured data. Robust error handling depends on consistent variant formatting to ensure reproducible oncology research.